Clinical Trial Update: Molecular and Cellular Mechanism in the Course of Immunotherapy With a Phleum Pratense Oral Lyophilisate [Phase 4]

View source ↗

Summary

A Phase 4 trial update reports the completion of a study examining the molecular and cellular mechanisms of immunotherapy using a Phleum pratense oral lyophilis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• Phleum pratense oral lyophilisate (Phleum pratense oral lyophilisate)

Snippet

Sponsor: ALK-Abelló A/S | Conditions: Allergic Rhinitis Due to Grass Pollens | Phase 4 | Status: COMPLETED